Janssen's Updated Phase 1 Results for Teclistamab in MM
93727 Helge Larsen/PI-redaktør 24/5 2021 14:46


Janssen's Updated Phase 1 Results for Teclistamab Suggest Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma
https://www.prnewswire.com/news-releases/janssens-updated-phase-1-results-for-teclistamab-suggest-deep-durable-responses-in-patients-with-heavily-pretreated-multiple-myeloma-301297610.html
https://www.prnewswire.com/news-releases/janssens-updated-phase-1-results-for-teclistamab-suggest-deep-durable-responses-in-patients-with-heavily-pretreated-multiple-myeloma-301297610.html